These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 17346227)

  • 1. Critical enzymes involved in endocannabinoid metabolism.
    Basavarajappa BS
    Protein Pept Lett; 2007; 14(3):237-46. PubMed ID: 17346227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into endocannabinoid degradation and its therapeutic potential.
    Bari M; Battista N; Fezza F; Gasperi V; Maccarrone M
    Mini Rev Med Chem; 2006 Mar; 6(3):257-68. PubMed ID: 16515464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet.
    Starowicz KM; Cristino L; Matias I; Capasso R; Racioppi A; Izzo AA; Di Marzo V
    Obesity (Silver Spring); 2008 Mar; 16(3):553-65. PubMed ID: 18239598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocannabinoid metabolic pathways and enzymes.
    Ligresti A; Cascio MG; Di Marzo V
    Curr Drug Targets CNS Neurol Disord; 2005 Dec; 4(6):615-23. PubMed ID: 16375679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo.
    Long JZ; Nomura DK; Vann RE; Walentiny DM; Booker L; Jin X; Burston JJ; Sim-Selley LJ; Lichtman AH; Wiley JL; Cravatt BF
    Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20270-5. PubMed ID: 19918051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocannabinoid regulation in human endometrium across the menstrual cycle.
    Scotchie JG; Savaris RF; Martin CE; Young SL
    Reprod Sci; 2015 Jan; 22(1):113-23. PubMed ID: 24819878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
    Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.
    Spoto B; Fezza F; Parlongo G; Battista N; Sgro' E; Gasperi V; Zoccali C; Maccarrone M
    Biochimie; 2006 Dec; 88(12):1889-97. PubMed ID: 16949718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation.
    Wang H; Xie H; Sun X; Kingsley PJ; Marnett LJ; Cravatt BF; Dey SK
    Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):62-74. PubMed ID: 17259073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain.
    Kinsey SG; Long JZ; O'Neal ST; Abdullah RA; Poklis JL; Boger DL; Cravatt BF; Lichtman AH
    J Pharmacol Exp Ther; 2009 Sep; 330(3):902-10. PubMed ID: 19502530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain regional cannabinoid CB(1) receptor signalling and alternative enzymatic pathways for 2-arachidonoylglycerol generation in brain sections of diacylglycerol lipase deficient mice.
    Aaltonen N; Riera Ribas C; Lehtonen M; Savinainen JR; Laitinen JT
    Eur J Pharm Sci; 2014 Jan; 51():87-95. PubMed ID: 24012970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol.
    Ho WS; Randall MD
    Br J Pharmacol; 2007 Mar; 150(5):641-51. PubMed ID: 17245358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulators of endocannabinoid enzymic hydrolysis and membrane transport.
    Ho WS; Hillard CJ
    Handb Exp Pharmacol; 2005; (168):187-207. PubMed ID: 16596775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice.
    Nicolussi S; Viveros-Paredes JM; Gachet MS; Rau M; Flores-Soto ME; Blunder M; Gertsch J
    Pharmacol Res; 2014 Feb; 80():52-65. PubMed ID: 24412246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocannabinoid modulation by FAAH and monoacylglycerol lipase within the analgesic circuitry of the periaqueductal grey.
    Lau BK; Drew GM; Mitchell VA; Vaughan CW
    Br J Pharmacol; 2014 Dec; 171(23):5225-36. PubMed ID: 25041240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors.
    Minkkilä A; Saario S; Nevalainen T
    Curr Top Med Chem; 2010; 10(8):828-58. PubMed ID: 20370710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation and biotransformation of the endogenous cannabinoids anandamide and 2-arachidonoylglycerol.
    Yates ML; Barker EL
    Mol Pharmacol; 2009 Jul; 76(1):11-7. PubMed ID: 19389920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms.
    Spradley JM; Guindon J; Hohmann AG
    Pharmacol Res; 2010 Sep; 62(3):249-58. PubMed ID: 20416378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biology of endocannabinoid synthesis system.
    Wang J; Ueda N
    Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):112-9. PubMed ID: 19126434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications.
    Pertwee RG
    Proc Nutr Soc; 2014 Feb; 73(1):96-105. PubMed ID: 24135210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.